APP and Alzheimer disease: The DEmiRNAs identified with the meta-analysis involved in Aβ metabolism, including APP expression, Aβ-production enzyme regulation, and Aβ clearance, tau protein phosphorylation, and also contribute to neuronal function during AD progression, including pathogenic neuroinflammation, apoptosis, mitochondrial oxygen chain activity, and neuronal microtubule maintenance.